Integrum establishes Center of Excellence in Ukraine

20 Dec 2023
www.prnewswire.com
MÖLNDAL, Sweden , Dec. 20, 2023 /PRNewswire/ --
Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has established a Center of Excellence at the Center for Complex Endoprosthetics, Osseointegration and Bionics in Kyiv, with the intention to spearhead orthopedic treatment using OPRA™ Implant System in individuals who have suffered limb loss.
The need for amputee care in Ukraine has increased rapidly since the Russian invasion. More than 20,000 individuals have lost extremities, which has put a high strain on the healthcare system and created a significant need for swift actions on an infrastructure level. The new Center of Excellence is operational following recent visits to Ukraine by Dr. Brånemark. Two senior surgeons have already been trained and certified to perform both transfemoral and transhumeral surgeries using Integrum's innovative OPRA™ Implant System.
More than 10 patients have already been treated using Integrum's implant system. This was initially done as a pro bono initiative by Dr. Brånemark and Integrum but is now also part of Integrum's commercial operations.
"Following our recent efforts in Ukraine, we have had constructive conversations with resourceful partners working tirelessly to restore war victims' health. We are proud to take part in the establishment of the Center of Excellence in Kyiv, which will function both as a medical center for the clinical care of patients who have suffered limb loss and as a beacon of knowledge for surgeons to learn how to perform reconstructive surgery using the OPRA™ Implant System," says Rickard Brånemark, CEO of Integrum.
For more information, please contact:
Rickard Brånemark, CEO
Phone: +46 (0) 70 846 10 61
E-mail: [email protected]
Jörgen Svanström, CFO
Phone: + 46 (0) 70 734 96 60
E-mail: [email protected]
Certified Adviser
Carnegie Investment Bank AB (publ) is Certified Adviser
The following files are available for download:
SOURCE Integrum AB
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.